Decrease in CD23+ B lymphocytes and clinical outcome in asthmatic patients receiving specific rush immunotherapy

International Archives of Allergy and Immunology

Volumn 111, Issue 2, 1996, Pages 188-194

  Kljaic Turkalj, Mirjana ^a   Cvoriscec, Branimir ^a   Tudoric, Neven ^a   Stipic Markovic, Asja ^a   Rabatic, Sabina ^b   Trescec, Andja ^b   Gagro, Alenka ^b   Dekaris, Dragan ^b  

^a Croatian Academy of Medical Sciences   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

CD23+ B cells; Der p; IgE; IgG4; Rush immunotherapy

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR DENSITY; TREATMENT OUTCOME;

EID: 0029775135     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237367     Document Type: Article

References (42)

1. Thompson RA: The current status of allergen immunotherapy (hyposensitization). Report of a WHO/IUIS working group. Allergy 1989;44: 369-379.
2. Mailing HJ: Immunotherapy in Europe. Clin Exp Allergy 1994;24:515-521.
3. Bousquet J, Hejjaoui A, Michel FB: Specific immunotherapy in asthma. J Allergy C’lin Immunol 1990;86:292-305.
4. Mailing HJ, Weekc B: EAACI immunotherapy. Position paper. Allergy 1993:48:9-35.
5. Hejjaoui A, Dhivcrt H, Michel FB, Bousquet J: Immunotherapy with a standardized Denmito-phagoides pteronyssinus extract. IV Systemic reaction according to the immunotherapy schedule. J Allergy Clin Immunol 1990:85: 473-479.
6. Durham SR, Varney V, Gaga M, Frew AJ, Jacobson M, Kay AB: Immunotherapy and allergic inflammation. Clin Exp Allergy 1991;21: 206-210.
7. Nakagawa T: The role of IgG subclass antibodies in the clinical response to immunotherapy in allergic disease. Clin Exp Allergy 1991;21: 289-296.
8. McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PV: A placebo controlled trial of immunotherapy with two extracts of Dermalopha-goides pteronyssinus in allergic rhinitis, comparing clinical outcome w ith changes in anti-gen-specific IgE, IgG and IgG subclasses. J Allergy Clin Immunol 1990:86:521-532.
9. Snapper CM, Mond JJ: Towards a comprehensive view' of immunoglobulin class switching. Immunol Today 1993; 14:15-17.
10. Aalberse RC, Dieges PH, Knul-Bretlova V, etal: IgG4 as blocking antibody. Clin Rev Allergy 1983;1:289-302.
11. Sarfati M, Dclespessc G: Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. J Immunol 1988;141:2195-2199.
12. Vercelli D, Geha RS: Regulation of IgE synthesis in humans: A talc of two signals. J Allergy Clin Immunol 1991;88:285-295.
13. Ricci M, Rossi O: Dysregulation of IgE responses and airway allergic inflammation in atopic individuals. Clin Exp Allergy 1990:20: 601-609.
14. Rabatic S, Gagro A, Medar-Lasic M: CD21 CD23 ligand pair expression in children with allergic asthma. Clin Exp.Immunol 1993:94: 337-340.
15. Ricci M, Rossi O, Bcrtoni M, Matucci A: The importance of TH2-like cells in the pathogenesis of airway allergic inflammation. Clin Exp Allergy 1993:23:360-369.
16. Te Velde A A, Rousset F, Peronne C, De Vries JE, Frigdor CG: INF-α and INF-γ have different regulatory effects on IL-4-induccd membrane expression of FCsRIIb and release of soluble FOR I lb by human monocytes. J Immunol 1990;144:3052-3059.
17. Kim KM, Mayumi M, Iwai Y, Tanaka M, Ito S, Shinomiya K, Mikawa H: IgE receptor-bearing lymphocytes in allergic and nonallergic children. PcdiatrRes 1988;24:254-257.
18. Aas K: Heterogeneity of bronchial asthma. Allergy 1998l;36:3-14.
19. Bousquet J, Hejjaoui A, Clauzel AM, Guerin B, Dhivert H, Skassa-Brocick W, Michel FB: Specific immunotherapy with a standarized Der-nuitophugoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. J Allergy Clin Immunol 1988:82:971-977.
20. Trescec A, Kolevska T, Cvoriscec B, Krnic B, Tudjman Z, Dekaris D: Characterization and partial purification of a Croatian national standard Oernutiopluigoides pteronyssinus allergen extract. Allergy 1993,48:454-459.
21. BSACI Position paper on immunotherapy. Clin Exp Allergy 1993;23:1-44.
22. Rak S: Effects of immunotherapy on the inflammation in pollen asthma. Allergy 1993:48:125-128.
23. Lichtenstein LM: Histamine-releasing factor and IgE heterogeneity. J Allergy Clin Immunol 1988:81:814-820.
24. Rak S, Bjömson A, Häkanson L, Sorenson S, Venge P: The effect of immunotherapy on eosinophil accumulation and production of eosinophil ehemotactic activity in the lungs of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-888.
25. Hedlin G, Silber G, Naclerio RM. Proud D, Lomas AM, Eggleston P, Adkinson NF: Comparison of the in vivo and in vitro response to ragweed immunotherapy in children and adults with ragwee-induced rhinitis. Clin Exp Allergy 1990:20:491-500.
26. Bousquet J, Calvayrac P, Guerin B, Hejjaoui A, Dhivert H, Hewitt B, Michel FB: Immunotherapy with a standarized Dennatopliagoidespteronyssinus extract. I. In vivo and in vitro parameters after a short treatment course. J Allergy Clin Immunol 1985;76:734-744.
27. Müller U, Mosbech H: Position paper: Immunotherapy w ith Hymenoptera venoms. Allergy 1993;48(suppl):37-46.
28. − cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990; 69:335-341.
29. Pastorello EA, Ortolani C, Inkorvaia C, Farioli L, Italia M, Prarettoni V, Harris KJ, Watson HK, Corrado OJ, Davies RJ, Zanussi C: A double-blind study of hyposensitization with an alginate-conjugate extract of Dermatophagoides pteronyssinus (Conjuvac R) in patients with perennial rhinitis. II. Immunological aspects. Allergy 1990:45:505-514.
30. Del Pretc G: Human Th 1 and Th2 lymphocytes: Their role in the pathophysiology of atopy. Allergy 1992;47:450-455.
31. Secrist II, Chelen CJ, Wen Y, Marshal JD, Umetsu DT: Allergen immunotherapy decreases interleukin 4 production in CD4+ T-cells from allergic individuals. J Exp Med 1993:178: 2123-2130.
32. Saxon A, Ke Z, Bahati L, Stevens RH: Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in inducing of IgE. J Allergy Clin Immunol 1990:86:333-344.
33. Penc J, Rousset F, Bricre F, et al: IgE production by normal human B-cells induced by alloreac-tive T-ccll clones is mediated by IL-4 and suppressed by INF-y. J Immunol 1988; 141:1218-1224.
34. Ikizawa K, Kajiwara K, Koshio T, Matsuura N, Yanagihara Y: Inhibition of IL-4 receptor up-regulation on B cells by antisense oligodeoxy-nuclcotide suppresses IL-4-induced human IgE production. Clin Exp Immunol 1995:100:383-389.
35. Luo HY, Hofstetter H, Banchereau J, Deles-pesse G: Cross-linking of CD23 antigen by its natural ligand (IgE) and by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. Immunol 1991;146:2122-2129.
36. Van der Heiden FL, van Neerven RJJ. van Kat-wijk M, Bos JD. Kapsenberg ML: Serum-IgE-faciktated allergen presentation in atopic disease. J Immunol 1993:150:3643-3650.
37. Secrist H, DeKruyff RH, Umetsu DT: Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and allergen presenting cell type. J Exp Med 1995:181:1081-1089.
38. Gagro A, Rabatic S, Trescec A, Dekaris D, Me-dar-Lasic M: Expression of FckR1I/CD23 lymphocytes in allergic children undergoing hyposensitization. Int Arch Allergy Immunol 1993; 101:203-208.
39. Takigawa M, Tamamori T, Horiguchi D, Sakamoto T, Yamada M, Yoskioka A, Toda K, Imam-ura S, Yodoi J: Fc epsilon recptor ll/CD23-posi-tive lymphocytes in atopic dermatitis. I. The proportion of Fc epsilon RII+ lymphocytes correlates with the extent of skin lesion. Clin Exp Immunol 1991;84:275-282.
40. Jung CM, Prinz JC, Rieber EP, Ring J: A reduction in allergen-induced FceR2/CD23 expression on peripheral B cells correlates with successful hyposensitization in grass pollinosis. J Allergy Clin Immunol 1995:95:77-87.
41. Dugas B, Paul-Eugene N, Cairns J, Gordon J, Calenda A, Manica-Huerta JM, Braquet P: Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23. and proliferation and differentiation of human B lymphocytes induced by IL-4. J Immunol 1990; 145:3406-3411.
42. Roper RL, Ludlow JW, Phipps RP: Prostaglandin E2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins. Cell Immunol 1994:154: 296-308.